Comparison between oral and enteral tube refeeding in hyperlipidemic acute pancreatitis
E.-X. Chen, J.-H. Tong, G. Che, Z.-F. She, X. Cao Department of General Surgery, Ordos Central Hospital, Inner Mongolia, China. 21969644@qq.com
OBJECTIVE: Hyperlipidemic acute pancreatitis (HLAP) remains one of the major digestive emergencies with increasing health risks. Oral refeeding tolerant (ORT) and enteral tube feeding tolerant (ETFT) are commonly used for nutritional management in HLAP. However, the differences between ORT and ETFT are yet to be characterized.
PATIENTS AND METHODS: This study included consecutive patients admitted to the Ordos Central Hospital between January 2019 and April 2023, with predefined inclusion criteria.
RESULTS: A total of 335 HLAP patients were recruited according to the inclusion criteria. 268 patients were diagnosed with moderately severe acute pancreatitis (MSAP), of which 193 were in the OFT group and 75 in the ETFT group. In the ETFT group, abdominal pain and abdominal distension were significantly higher than that in the OFT group. No significant result was identified in the laboratory data. However, the OFT group showed a higher hospitalization and cost, as well as exocrine insufficiency and newly onset diabetes, than the ETFT group.
CONCLUSIONS: Based on the incidence of HLAP retrieved in this study, MSAP is the major type with increasing clinical value. From the nutritional management sense, patients who received OFT showed higher hospitalization and cost, as well as lower exocrine insufficiency and newly onset diabetes.
Free PDF DownloadThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
E.-X. Chen, J.-H. Tong, G. Che, Z.-F. She, X. Cao
Comparison between oral and enteral tube refeeding in hyperlipidemic acute pancreatitis
Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 19
Pages: 9309-9314
DOI: 10.26355/eurrev_202310_33958